DUBLIN, Jan. 17, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Drug Delivery Technology Market by Route of Administration, Patient Care Setting - Global Forecast to 2021" report to their offering.
The drug delivery technology market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period. Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are some of the major factors driving the growth of the market.
Furthermore, self-administration & home care and rising demand for biosimilars and generic drugs offer significant growth opportunities for player operating in the market. On the other hand, risk of needle-stick injuries and side effects of drugs may restraint the growth of the market.
The market is segmented based on route of administration, facility of use, and region. Based on route of administration, the market is segmented into oral, injectable, topical, nasal, ocular, pulmonary, implantable, and transmucosal. In 2016, the oral drug delivery segment is expected to account for the largest share of the market. This can be attributed to the factors such as, orally administered drugs can be conveniently stored and are portable, economical, noninvasive, and safe. No special training is required for the administration of these drugs, which is a major factor driving the growth of this market.
Based on facility of use, the drug delivery technology market is segmented into the hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers, and other facilities of use. In 2016, the hospitals segment is expected to account for the largest share of the market. This can be primarily attributed to factors such as the significant number of inpatient and outpatient visits in hospitals as compared to other end users and the requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool. Additionally, the increasing need for drug administration due to the rising prevalence of chronic diseases, patient compliance, and safety are all factors contributing to the growth of the market for hospitals.
- Antares Pharma, Inc.
- Bayer AG
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- Glaxosmithkline PLC
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Regulatory Scenario
7 Drug Delivery Technology Market, By Route of Administration
8 Drug Delivery Technology Market, By Facility of Use
9 Drug Delivery Technology Market, By Region
10 Competitive Landscape
11 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/wp3mwr/drug_delivery
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets